Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-407

"For IGA, in Australia, 14.4% of combined active groups achieved a 2-grade reduction over the Phase 2 Study compared to only 7.4% of combined vehicle groups. In the USA, 15.2% of combined active groups achieving a 2-grade reduction over the Study compared to 16.9% of combined vehicle groups."

Again these results appear to be in line with the Foamix ph3 results. They're also inline with the primary end point results, showing efficacy in both the US and Oz but only good separation from the vehicle in Oz. Again, this is consistent with there being some sort of error in the trial/data in the US